Biologic Imaging Contrast Agent Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (CT Contrast Reagents, Magnetic Resonance Imaging (MRI) Contrast Reagents, and Ultrasound Contrast Reagents); End Use ( Hospitals, Clinics, and Other), and Geography

Report Code: TIPRE00022279 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Biologic Imaging is an imaging technique used in medical imaging. Contrast agents are the substances used to increase the contrast of fluids within the body in medical imaging. These substances absorb or even change external electromagnetism or ultrasound which emits radiations. With the increase in approvals of contrast agents, as well as technological advancements the biologic imaging contrast agent market is growing.

MARKET DYNAMICS

Factors driving the growth of the biologic imaging contrast agent market are increase in the demand for imaging technologies, and growth in cancer populace. However, side effects and rise in research activities are likely to hamper the growth of the market. Moreover, technology advancements in the biologic imaging contrast agent is further likely to create growth opportunities in the market.

MARKET SCOPE

The "Biologic Imaging Contrast Agent Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of biologic imaging contrast agent market with detailed market segmentation by product, and end use. The biologic imaging contrast agent market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in biologic imaging contrast agent market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The biologic imaging contrast agent market is segmented on the basis of product, and end use. On the basis of type of product, the market is categorized as ct contrast reagents, magnetic resonance imaging (mri) contrast reagents, ultrasound contrast reagents. On the basis of end use, the market is categorized as hospitals, clinics, other.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the biologic imaging contrast agent market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The biologic imaging contrast agent market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting biologic imaging contrast agent market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the biologic imaging contrast agent market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the biologic imaging contrast agent market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from biologic imaging contrast agent market are anticipated to have lucrative growth opportunities in the future with the rising demand for biologic imaging contrast agent in the global market. Below mentioned is the list of few companies engaged in the biologic imaging contrast agent market.

The report also includes the profiles of key players in biologic imaging contrast agent market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years.
  •  Bracco
  •  Bayer HealthCare
  •  Hengrui Medicine
  •  GE Healthcare
  •  YRPG
  •  BeiLu Pharma
  •  Guerbet
  •  Starry Pharmaceutical
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Biologic Imaging Contrast Agent Market - By Product
1.3.2 Biologic Imaging Contrast Agent Market - By End Use
1.3.3 Biologic Imaging Contrast Agent Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BIOLOGIC IMAGING CONTRAST AGENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BIOLOGIC IMAGING CONTRAST AGENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BIOLOGIC IMAGING CONTRAST AGENT MARKET - GLOBAL MARKET ANALYSIS
6.1. BIOLOGIC IMAGING CONTRAST AGENT - GLOBAL MARKET OVERVIEW
6.2. BIOLOGIC IMAGING CONTRAST AGENT - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. BIOLOGIC IMAGING CONTRAST AGENT MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. CT CONTRAST REAGENTS
7.3.1. Overview
7.3.2. CT Contrast Reagents Market Forecast and Analysis
7.4. MAGNETIC RESONANCE IMAGING (MRI) CONTRAST REAGENTS
7.4.1. Overview
7.4.2. Magnetic Resonance Imaging (MRI) Contrast Reagents Market Forecast and Analysis
7.5. ULTRASOUND CONTRAST REAGENTS
7.5.1. Overview
7.5.2. Ultrasound Contrast Reagents Market Forecast and Analysis
8. BIOLOGIC IMAGING CONTRAST AGENT MARKET - REVENUE AND FORECASTS TO 2028 - END USE
8.1. OVERVIEW
8.2. END USE MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis
8.5. OTHER
8.5.1. Overview
8.5.2. Other Market Forecast and Analysis
9. BIOLOGIC IMAGING CONTRAST AGENT MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Biologic Imaging Contrast Agent Market Overview
9.1.2 North America Biologic Imaging Contrast Agent Market Forecasts and Analysis
9.1.3 North America Biologic Imaging Contrast Agent Market Forecasts and Analysis - By Product
9.1.4 North America Biologic Imaging Contrast Agent Market Forecasts and Analysis - By End Use
9.1.5 North America Biologic Imaging Contrast Agent Market Forecasts and Analysis - By Countries
9.1.5.1 United States Biologic Imaging Contrast Agent Market
9.1.5.1.1 United States Biologic Imaging Contrast Agent Market by Product
9.1.5.1.2 United States Biologic Imaging Contrast Agent Market by End Use
9.1.5.2 Canada Biologic Imaging Contrast Agent Market
9.1.5.2.1 Canada Biologic Imaging Contrast Agent Market by Product
9.1.5.2.2 Canada Biologic Imaging Contrast Agent Market by End Use
9.1.5.3 Mexico Biologic Imaging Contrast Agent Market
9.1.5.3.1 Mexico Biologic Imaging Contrast Agent Market by Product
9.1.5.3.2 Mexico Biologic Imaging Contrast Agent Market by End Use
9.2. EUROPE
9.2.1 Europe Biologic Imaging Contrast Agent Market Overview
9.2.2 Europe Biologic Imaging Contrast Agent Market Forecasts and Analysis
9.2.3 Europe Biologic Imaging Contrast Agent Market Forecasts and Analysis - By Product
9.2.4 Europe Biologic Imaging Contrast Agent Market Forecasts and Analysis - By End Use
9.2.5 Europe Biologic Imaging Contrast Agent Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Biologic Imaging Contrast Agent Market
9.2.5.1.1 Germany Biologic Imaging Contrast Agent Market by Product
9.2.5.1.2 Germany Biologic Imaging Contrast Agent Market by End Use
9.2.5.2 France Biologic Imaging Contrast Agent Market
9.2.5.2.1 France Biologic Imaging Contrast Agent Market by Product
9.2.5.2.2 France Biologic Imaging Contrast Agent Market by End Use
9.2.5.3 Italy Biologic Imaging Contrast Agent Market
9.2.5.3.1 Italy Biologic Imaging Contrast Agent Market by Product
9.2.5.3.2 Italy Biologic Imaging Contrast Agent Market by End Use
9.2.5.4 Spain Biologic Imaging Contrast Agent Market
9.2.5.4.1 Spain Biologic Imaging Contrast Agent Market by Product
9.2.5.4.2 Spain Biologic Imaging Contrast Agent Market by End Use
9.2.5.5 United Kingdom Biologic Imaging Contrast Agent Market
9.2.5.5.1 United Kingdom Biologic Imaging Contrast Agent Market by Product
9.2.5.5.2 United Kingdom Biologic Imaging Contrast Agent Market by End Use
9.2.5.6 Rest of Europe Biologic Imaging Contrast Agent Market
9.2.5.6.1 Rest of Europe Biologic Imaging Contrast Agent Market by Product
9.2.5.6.2 Rest of Europe Biologic Imaging Contrast Agent Market by End Use
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Biologic Imaging Contrast Agent Market Overview
9.3.2 Asia-Pacific Biologic Imaging Contrast Agent Market Forecasts and Analysis
9.3.3 Asia-Pacific Biologic Imaging Contrast Agent Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Biologic Imaging Contrast Agent Market Forecasts and Analysis - By End Use
9.3.5 Asia-Pacific Biologic Imaging Contrast Agent Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Biologic Imaging Contrast Agent Market
9.3.5.1.1 Australia Biologic Imaging Contrast Agent Market by Product
9.3.5.1.2 Australia Biologic Imaging Contrast Agent Market by End Use
9.3.5.2 China Biologic Imaging Contrast Agent Market
9.3.5.2.1 China Biologic Imaging Contrast Agent Market by Product
9.3.5.2.2 China Biologic Imaging Contrast Agent Market by End Use
9.3.5.3 India Biologic Imaging Contrast Agent Market
9.3.5.3.1 India Biologic Imaging Contrast Agent Market by Product
9.3.5.3.2 India Biologic Imaging Contrast Agent Market by End Use
9.3.5.4 Japan Biologic Imaging Contrast Agent Market
9.3.5.4.1 Japan Biologic Imaging Contrast Agent Market by Product
9.3.5.4.2 Japan Biologic Imaging Contrast Agent Market by End Use
9.3.5.5 South Korea Biologic Imaging Contrast Agent Market
9.3.5.5.1 South Korea Biologic Imaging Contrast Agent Market by Product
9.3.5.5.2 South Korea Biologic Imaging Contrast Agent Market by End Use
9.3.5.6 Rest of Asia-Pacific Biologic Imaging Contrast Agent Market
9.3.5.6.1 Rest of Asia-Pacific Biologic Imaging Contrast Agent Market by Product
9.3.5.6.2 Rest of Asia-Pacific Biologic Imaging Contrast Agent Market by End Use
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Biologic Imaging Contrast Agent Market Overview
9.4.2 Middle East and Africa Biologic Imaging Contrast Agent Market Forecasts and Analysis
9.4.3 Middle East and Africa Biologic Imaging Contrast Agent Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Biologic Imaging Contrast Agent Market Forecasts and Analysis - By End Use
9.4.5 Middle East and Africa Biologic Imaging Contrast Agent Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Biologic Imaging Contrast Agent Market
9.4.5.1.1 South Africa Biologic Imaging Contrast Agent Market by Product
9.4.5.1.2 South Africa Biologic Imaging Contrast Agent Market by End Use
9.4.5.2 Saudi Arabia Biologic Imaging Contrast Agent Market
9.4.5.2.1 Saudi Arabia Biologic Imaging Contrast Agent Market by Product
9.4.5.2.2 Saudi Arabia Biologic Imaging Contrast Agent Market by End Use
9.4.5.3 U.A.E Biologic Imaging Contrast Agent Market
9.4.5.3.1 U.A.E Biologic Imaging Contrast Agent Market by Product
9.4.5.3.2 U.A.E Biologic Imaging Contrast Agent Market by End Use
9.4.5.4 Rest of Middle East and Africa Biologic Imaging Contrast Agent Market
9.4.5.4.1 Rest of Middle East and Africa Biologic Imaging Contrast Agent Market by Product
9.4.5.4.2 Rest of Middle East and Africa Biologic Imaging Contrast Agent Market by End Use
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Biologic Imaging Contrast Agent Market Overview
9.5.2 South and Central America Biologic Imaging Contrast Agent Market Forecasts and Analysis
9.5.3 South and Central America Biologic Imaging Contrast Agent Market Forecasts and Analysis - By Product
9.5.4 South and Central America Biologic Imaging Contrast Agent Market Forecasts and Analysis - By End Use
9.5.5 South and Central America Biologic Imaging Contrast Agent Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Biologic Imaging Contrast Agent Market
9.5.5.1.1 Brazil Biologic Imaging Contrast Agent Market by Product
9.5.5.1.2 Brazil Biologic Imaging Contrast Agent Market by End Use
9.5.5.2 Argentina Biologic Imaging Contrast Agent Market
9.5.5.2.1 Argentina Biologic Imaging Contrast Agent Market by Product
9.5.5.2.2 Argentina Biologic Imaging Contrast Agent Market by End Use
9.5.5.3 Rest of South and Central America Biologic Imaging Contrast Agent Market
9.5.5.3.1 Rest of South and Central America Biologic Imaging Contrast Agent Market by Product
9.5.5.3.2 Rest of South and Central America Biologic Imaging Contrast Agent Market by End Use
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL BIOLOGIC IMAGING CONTRAST AGENT MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. BIOLOGIC IMAGING CONTRAST AGENT MARKET, KEY COMPANY PROFILES
12.1. BRACCO
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BAYER HEALTHCARE
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. HENGRUI MEDICINE
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. GE HEALTHCARE
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. YRPG
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BEILU PHARMA
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. GUERBET
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. STARRY PHARMACEUTICAL
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Bracco
2. Bayer HealthCare
3. Hengrui Medicine
4. GE Healthcare
5. YRPG
6. BeiLu Pharma
7. Guerbet
8. Starry Pharmaceutical
TIPRE00022279
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking